Fumery, M., Peyrin-Biroulet, L., Nancey, S., Altwegg, R., Gilletta, C., Veyrard, P., Bouguen, G., Viennot, S., Poullenot, F., Filippi, J., Buisson, A., Bozon, A., Brazier, F., Pouillon, L., Flourie, B., Boivineau, L., Siproudhis, L., Laharie, D., Roblin, X., Diouf, M., & Treton, X. (2021). effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study. Journal of Crohn's and colitis, 15, 222–227. http://access.bl.uk/ark:/81055/vdc_100121927727.0x000024